PPIDT00492
Drug Information
| Name | Tisotumab vedotin |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB16732 |
| Type | biotech |
| Indication | Tisotumab vedotin is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.[L50602] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, powder, for solution | Intravenous |
40 mg/4mL
|